CIK 0001636282
- Large accelerated filer
Spyre Therapeutics, Inc.
Sign in to watch- Ticker
- SYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464312787
- Phone
- +1 617-651-5940
- Business address
- 221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- Aeglea BioTherapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,349,597
- in 6 filings, $12.3M under 10b5-1 plans
Net −$12,349,597. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 21 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-21 | Quinn Anthony G. President & CEO | Purchase | +13,794 | $6.89 | $95K | 317,929 |
| 2019-05-20 | Quinn Anthony G. President & CEO | Purchase | +8,989 | $6.56 | $59K | 304,135 |
| 2019-05-17 | Quinn Anthony G. President & CEO | Purchase | +6,218 | $6.65 | $41K | 295,146 |
| 2019-05-16 | Quinn Anthony G. President & CEO | Purchase | +5,520 | $6.83 | $38K | 288,928 |
| 2019-05-15 | Quinn Anthony G. President & CEO | Purchase | +6,256 | $6.76 | $42K | 283,408 |
| 2019-03-06 | Sloan Leslie Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +36,000 | 36,000 | ||
| 2019-02-28 | York Charles N II Chief Financial Officer and VP | Grant or award · Employee Stock Option (right to buy) | +87,600 | 87,600 | ||
| 2019-02-28 | Wooldridge James Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +50,200 | 50,200 | ||
| 2019-02-28 | Schuchart Aaron Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2019-02-28 | Quinn Anthony G. President & CEO | Grant or award · Stock Option (right to buy) | +280,000 | 280,000 | ||
| 2019-02-15 | Quinn Anthony G. President & CEO | Purchase | +719 | $7.10 | $5K | 277,152 |
| 2019-02-06 | Quinn Anthony G. President & CEO | Option exercise | +1,323 | $5.46 | $7K | 269,000 |
| 2019-02-06 | Quinn Anthony G. President & CEO | Option exercise | +7,433 | $6.31 | $47K | 276,433 |
| 2019-02-06 | Quinn Anthony G. President & CEO | Option exercise · Stock Option (right to buy) | −1,323 | 662 | ||
| 2019-02-06 | Quinn Anthony G. President & CEO | Option exercise · Stock Option (right to buy) | −7,433 | 137,517 | ||
| 2018-12-07 | Quinn Anthony G. President & CEO | Option exercise | +150,000 | $4.11 | $617K | 245,787 |
| 2018-12-07 | Quinn Anthony G. President & CEO | Option exercise | +3,306 | $5.46 | $18K | 249,093 |
| 2018-12-07 | Quinn Anthony G. President & CEO | Option exercise | +18,584 | $6.31 | $117K | 267,677 |
| 2018-12-07 | Quinn Anthony G. President & CEO | Option exercise · Director Stock Option (right to buy) | −150,000 | 0 | ||
| 2018-12-07 | Quinn Anthony G. President & CEO | Option exercise · Director Stock Option (right to buy) | −3,306 | 1,985 |
Page 15 of 19 · 372 trades